These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19626398)

  • 1. Baseline inflammation is not predictive of periprocedural troponin elevation after elective percutaneous coronary intervention.
    Gach O; Louis O; Chapelle JP; Vanbelle S; Pierard LA; Legrand V
    Heart Vessels; 2009 Jul; 24(4):267-70. PubMed ID: 19626398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome in high risk patients with unprotected left main coronary artery stenosis treated with percutaneous coronary intervention.
    Jensen LO; Kaltoft A; Thayssen P; Tilsted HH; Christiansen EH; Mikkelsen KV; Maeng M; Hansen KN; Villadsen AB; Madsen M; Lassen JF; Pedersen KE; Thuesen L
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):101-8. PubMed ID: 19670299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary intervention.
    Mangiacapra F; Barbato E; Patti G; Gatto L; Vizzi V; Ricottini E; D'Ambrosio A; Wijns W; Di Sciascio G
    JACC Cardiovasc Interv; 2010 Mar; 3(3):318-23. PubMed ID: 20298992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris.
    Bertinchant JP; Polge A; Ledermann B; Genet L; Fabbro-Peray P; Raczka F; Brunet J; Poirey S; Wittenberg O; Pernel I; Nigond J
    Am J Cardiol; 1999 Jul; 84(1):51-7. PubMed ID: 10404851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of micro troponin leak on long-term outcomes following elective percutaneous coronary intervention.
    Milani RV; Fitzgerald R; Milani JN; Lavie CJ
    Catheter Cardiovasc Interv; 2009 Nov; 74(6):819-22. PubMed ID: 19670308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of plaque composition on cardiac troponin elevation after percutaneous coronary intervention: an ultrasound analysis.
    Hong YJ; Mintz GS; Kim SW; Lee SY; Okabe T; Pichard AD; Satler LF; Waksman R; Kent KM; Suddath WO; Weissman NJ
    JACC Cardiovasc Imaging; 2009 Apr; 2(4):458-68. PubMed ID: 19580729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic implications of C-reactive protein and troponin following percutaneous coronary intervention.
    Hubacek J; Basran RS; Shrive FM; Shewchuk L; Goodhart DM; Anderson TJ;
    Can J Cardiol; 2009 Feb; 25(2):e42-7. PubMed ID: 19214300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosuvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of myocardial periprocedural necrosis: the ROMA trial.
    Sardella G; Conti G; Donahue M; Mancone M; Canali E; De Carlo C; Di Roma A; Calcagno S; Lucisano L; Fedele F
    Catheter Cardiovasc Interv; 2013 Jan; 81(1):E36-43. PubMed ID: 22517610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention.
    Nageh T; Sherwood RA; Harris BM; Byrne JA; Thomas MR
    Int J Cardiol; 2003 Dec; 92(2-3):285-93. PubMed ID: 14659867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic value of a careful symptom evaluation and high sensitive troponin in patients with suspected stable angina pectoris without prior cardiovascular disease.
    Madsen DM; Diederichsen ACP; Hosbond SE; Gerke O; Mickley H
    Atherosclerosis; 2017 Mar; 258():131-137. PubMed ID: 28031149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of pravastatin pre-treatment on periprocedural microcirculatory damage in patients undergoing percutaneous coronary intervention.
    Fujii K; Kawasaki D; Oka K; Akahori H; Iwasaku T; Fukunaga M; Eguchi A; Sawada H; Masutani M; Lee-Kawabata M; Tsujino T; Ohyanagi M; Masuyama T
    JACC Cardiovasc Interv; 2011 May; 4(5):513-20. PubMed ID: 21596324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac troponin I increase after successful percutaneous coronary angioplasty: predictors and long-term prognostic value.
    Okmen E; Cam N; Sanli A; Unal S; Tartan Z; Vural M
    Angiology; 2006; 57(2):161-9. PubMed ID: 16518523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality.
    Kini AS; Lee P; Marmur JD; Agarwal A; Duffy ME; Kim MC; Sharma SK
    Am J Cardiol; 2004 Jan; 93(1):18-23. PubMed ID: 14697460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of significant non-infarct-related left main coronary artery disease in patients with acute myocardial infarction who receive a culprit-lesion percutaneous coronary intervention.
    Seo SM; Kim TH; Kim CJ; Hwang BH; Kang MK; Koh YS; Min J; Chang K; Kim PJ; Park HJ; Chung WS; Jeong MH; Kim YJ; Park SJ; Seung KB;
    Coron Artery Dis; 2012 Aug; 23(5):307-14. PubMed ID: 22527385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac troponin I for risk stratification following percutaneous coronary artery intervention in acute coronary syndromes.
    Nageh T; Sherwood RA; Harris BM; Thomas MR
    Catheter Cardiovasc Interv; 2002 Jan; 55(1):37-42. PubMed ID: 11793493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intracoronary nicardipine on cardiac enzymes after elective percutaneous coronary intervention.
    Arora S; Alfayoumi F; Khawaja AT; Dua A; Srinivasan V; Gradman AH
    Clin Cardiol; 2009 Jun; 32(6):315-20. PubMed ID: 19569065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary stent length predicts PCI-induced cardiac myonecrosis.
    Hoole SP; Heck PM; Sharples L; Dutka DP; West NE
    Coron Artery Dis; 2010 Aug; 21(5):312-7. PubMed ID: 20555263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of liposomal prostaglandin E1 on periprocedural myocardial injury in patients with unstable angina undergoing an elective percutaneous coronary intervention.
    Fan Y; Jiang Y; Fu X; Cai J; Wang Y; Li W; Gu X; Xing K; Bai S; Bi X
    Coron Artery Dis; 2015 Dec; 26(8):671-7. PubMed ID: 26267747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience.
    Chieffo A; Magni V; Latib A; Maisano F; Ielasi A; Montorfano M; Carlino M; Godino C; Ferraro M; Calori G; Alfieri O; Colombo A
    JACC Cardiovasc Interv; 2010 Jun; 3(6):595-601. PubMed ID: 20630452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term prognostic significance of high-sensitivity C-reactive protein before and after coronary angioplasty in patients with stable angina pectoris.
    Gach O; Legrand V; Biessaux Y; Chapelle JP; Vanbelle S; Pierard LA
    Am J Cardiol; 2007 Jan; 99(1):31-5. PubMed ID: 17196457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.